Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV001024611 | SCV001186653 | uncertain significance | Hereditary cancer-predisposing syndrome | 2024-09-06 | criteria provided, single submitter | clinical testing | The p.W195* variant (also known as c.585G>A), located in coding exon 1 of the HOXB13 gene, results from a G to A substitution at nucleotide position 585. This changes the amino acid from a tryptophan to a stop codon within coding exon 1. This alteration occurs at the 3' terminus of theHOXB13 gene, is not expected to trigger nonsense-mediated mRNAdecay, and only impacts the last 32% of the protein. The exact functional effect of this alteration is unknown. Based on the available evidence, the clinical significance of this alteration remains unclear. |
Laboratory for Genotyping Development, |
RCV003160182 | SCV002758216 | pathogenic | Gastric cancer | 2021-07-01 | no assertion criteria provided | research |